Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease

Alzheimer's and Dementia

Volumn 7, Issue 3, 2011, Pages 300-308

  Marshall, Gad A ^a,b   Rentz, Dorene M ^a,b   Frey, Meghan T ^a,b   Locascio, Joseph J ^b   Johnson, Keith A ^a,b   Sperling, Reisa A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Executive function; Instrumental activities of daily living; Memory; Mild cognitive impairment

Indexed keywords

ADL DISABILITY; AGED; ALZHEIMER DISEASE; APATHY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DIAGNOSIS RELATED GROUP; EXECUTIVE DYSFUNCTION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INSTRUMENTAL DAILY LIFE ACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; COHORT STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT;

EID: 79956105154     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2010.04.005     Document Type: Article

References (42)

1. Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20:56-9. (Pubitemid 44356895)
2. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007;68:1718-25. (Pubitemid 46763260)
3. Salmon E, Lespagnard S, Marique P, Peeters F, Herholz K, Perani D, et al. Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol 2005;252:283-90. (Pubitemid 40562161)
4. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003;11:214-21. (Pubitemid 36254195)
5. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000;55:1847-53. (Pubitemid 32103967)
6. Chen ST, Sultzer DL, Hinkin CH, Mahler ME, Cummings JL. Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment. J Neuropsychiatry Clin Neurosci 1998;10:426-32. (Pubitemid 28505394)
7. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758-64. (Pubitemid 34211555)
8. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol 2002;9:187-91. (Pubitemid 36134212)
9. Royall DR, Palmer R, Chiodo LK, Polk MJ. Declining executive control in normal aging predicts change in functional status: the Freedom House Study. J Am Geriatr Soc 2004;52:346-52. (Pubitemid 38339513)
10. Razani J, Casas R, Wong JT, Lu P, Alessi C, Josephson K. Relationship between executive functioning and activities of daily living in patients with relatively mild dementia. Appl Neuropsychol 2007;14:208-14.
11. Cahn-Weiner DA, Farias ST, Julian L, Harvey DJ, Kramer JH, Reed BR, Mungas D, Wetzel M, Chui H. Cognitive and neuroimaging predictors of instrumental activities of daily living. J Int Neuropsychol Soc 2007;13:747-57. (Pubitemid 47299444)
12. Pereira FS, Yassuda MS, Oliveira AM, Forlenza OV. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr 2008;20:1104-15.
13. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's disease neuro-imaging initiative. Neuroimaging Clin N Am 2005;15:869-77.
14. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-8. (Pubitemid 10073130)
15. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, ed. Clinical Gerontology:A Guide to Assessment and Intervention. New York, NY: The Haworth Press; 1986. p. 165-73.
16. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-4. (Pubitemid 23346995)
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Weschler D. WMS-R Weschler Memory Scale Revised Manual. New York, NY: The Psychological Corporation/Harcourt Brace Jovanovich, Inc; 1987.
19. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-94. (Pubitemid 39222988)
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
21. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-9. (Pubitemid 12117513)
22. Nitrini R, Caramelli P, Herrera E Jr, Bahia VS, Caixeta LF, Radanovic M, et al. Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2004;18:241-6. (Pubitemid 40076156)
23. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-6.
24. Wechsler D. WAIS-R Manual. New York, NY: The Psychological Corporation; 1981.
25. Bell-McGinty S, Podell K, Franzen M, Baird AD, Williams MJ. Standard measures of executive function in predicting instrumental activities of daily living in older adults. Int J Geriatr Psychiatry 2002;17:828-34.
26. Royall DR, Lauterbach EC, Kaufer D, Malloy P, Coburn KL, Black KJ. Committee on Research of the American Neuropsychiatric Association. The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2007;19:249-65. (Pubitemid 47293898)
27. Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK. Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry Neuropsychol Behav Neurol 2002;15:39-43. (Pubitemid 34213815)
28. Rey A. L'examen Clinique en Psychologie. Paris, France: Presses Universitaires de France; 1964.
29. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000;12:233-9. (Pubitemid 30303778)
30. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91-101.
31. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associated Publishers; 1988.
32. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996;103:403-28. (Pubitemid 126432206)
33. Salthouse TA. Relations between cognitive abilities and measures of executive functioning. Neuropsychology 2005;19:532-45. (Pubitemid 41077135)
34. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6:501-12. (Pubitemid 46738627)
35. Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, et al. GAL-INT-11/18 Study Group. Safety and efficacy of galantamine in subjectswithmild cognitive impairment.Neurology 2008;70:2024-35.
36. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. (Pubitemid 40958434)
37. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8. (Pubitemid 29120227)
38. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-41. (Pubitemid 40316322)
39. Jicha GA, Parisi JE, Dickson DW, Johnson K, Char R, Ivnik RJ, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006;63:674-81.
40. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006;63:665-72.
41. Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, et al. Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 2009;65:557-68.
42. Johnson JK, Lui LY, Yaffe K. Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci 2007;62:1134-41. (Pubitemid 47599425)